Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

105.83
Delayed Data
As of 3:59pm ET
 -1.57 / -1.46%
Today’s Change
93.05
Today|||52-Week Range
128.39
-11.63%
Year-to-Date
Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?
11:04am / MotleyFool.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
The 3 Best-Run Companies in the Healthcare Sector
Sep 27 / MotleyFool.com - Paid Partner Content
The Most Exciting Drug in Celgene's Pipeline
Sep 21 / MotleyFool.com - Paid Partner Content
Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients
Sep 27 / TheStreet.com - Paid Partner Content
Celgene Presents Efficacy & Safety Phase II Ozanimod Data
Sep 20 / Zacks.com - Paid Partner Content
Biotech ETFs May Be a Prescription for Investment Success, Especially If Trump Become...
Sep 26 / TheStreet.com - Paid Partner Content
3 Top Stocks on Sale This Fall
Sep 19 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Sep 26 / MotleyFool.com - Paid Partner Content
5 Reasons Celgene Is a Buy
Sep 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close107.40
Today’s open107.62
Day’s range105.45 - 107.62
Volume4,713,821
Average volume (3 months)4,272,450
Market cap$83.2B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+22.49%
Earnings growth (next 5 years)+20.49%
Revenue growth (last year)+16.47%
P/E ratio44.5
Price/Sales11.10
Price/Book14.27

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.21+0.62%
NVONovo Nordisk-0.11-0.25%
LLYEli Lilly and Co-0.17-0.21%
BMYBristol-Myers Squibb-0.65-1.17%
Data as of 4:02pm ET, 09/28/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.48
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Search for Jobs